ISRCTN15259645已完成1 期
A phase I, randomized, double-blind, multiple-ascending-dose study to evaluate the safety and pharmacokinetics of GDC-5780 in healthy subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 18 - 65 years at time of signing informed consent form (ICF)
- •2. Body mass index (BMI) of = 18.5 and < 30 kilograms per metre squared (kg/m^2) at screening
- •3. Ability to comply with study protocol
排除标准
- •1. Pregnancy or breastfeeding, or intention of becoming pregnant during the study or within 28 days after the final dose of study drug
- •2. Planned procedure or surgery during the study
- •3. Positive human immunodeficiency virus (HIV) test at screening
- •4. Positive hepatitis B surface antigen (HBsAg) test at screening
- •5. Positive hepatitis C virus (HCV) antibody test at screening
- •6. Any serious medical condition or abnormality in clinical laboratory tests
- •7. History of malignancy within 5 years prior to screening
- •8. Acute illness within 14 days prior to screening
- •9. Vaccination within 14 days prior to initiation of study drug
研究者
相似试验
进行中（未招募）
1 期
Safety assessment of cord blood mesenchymal stromal cells in chronic spinal cord injuryEUCTR2015-005786-23-ESBanc de Sang i Teixits
进行中（未招募）
1 期
A study to evaluate safety and pharmacokinetics (processing by the body) of single ascending doses of GDC-5780 in healthy participantsISRCTN16073754Roche (United States)56
尚未招募
1 期
Treatment of abnormal uterine bleedingAbnormal Uterine BleedingPACTR202310719625892Avana Health20
已完成
不适用
A Phase I, single*center, double-blind, randomized, placebo-controlled, single and multiple ascending dose trial to evaluate the safety and pharmacokinetics of PTC857 in healthy volunteers.10007951Parkinson's DiseaseNL-OMON49571PTC Therapeutics, Inc.82
进行中（未招募）
不适用
Safety and immunogenicity study of GlaxoSmithKline (GSK) Biologicals’ pneumococcal vaccine 2830930A when given as 1 dose to healthy toddlers aged 12-23 months.EUCTR2011-002225-22-DEGlaxoSmithKline Biologicals